First Week of February 20th Options Trading For Corebridge Financial (CRBG)

Corebridge Financial (CRBG) is presented as an options income candidate at a current stock price of $30.36: a $25 put can be sold for $0.05 (cost basis if assigned $24.95), representing an ~18% downside strike with an 87% probability of expiring worthless and a 0.20% return (1.66% annualized). On the call side, a $31 covered call can be sold for $0.95, putting potential total return at 5.24% to February 20 expiration (3.13% if the call expires worthless, 25.96% annualized). Implied volatilities are 54% for the put and 37% for the call versus a trailing 12-month volatility of 36%, and Stock Options Channel will track odds and contract charts over time.

Analysis

Market structure: The option flow described benefits option sellers and yield-seeking equity holders — selling the Feb $25 put for $0.05 implies an 87% modeled chance to keep premium and a de facto entry price of $24.95 versus the $30.36 spot. Covered-call sellers at $31 (0.95 credit) capture 5.24% to assignment or 3.13% if options expire worthless, showing demand for income trades against a stock trading ~2% below that strike. The skew (puts IV 54% vs calls 37%) signals asymmetric downside concern priced by markets.

Risk assessment: Immediate (days) risk is limited to option time-decay outcomes tied to Feb 20 expiry; short-term (weeks/months) tail risks include a sudden insurer-specific loss, a regulatory capital move, or a >50bp UST move that re-rates liabilities and raises realized volatility. Hidden dependency: assignment risk and funding (margin) strain if multiple puts are exercised into a cash-heavy insurance balance sheet; second-order effects include forced selling into thin liquidity. Key catalysts: Feb 20 expiry, quarterly results/earnings, and 10y Treasury moves >25–50bp.

Trade implications: Direct plays — structured income trades look attractive: sell defined-risk put spreads or run covered calls to harvest the 3–5% near-term yields while limiting tail losses; avoid naked short-delta exposure >2–3% notional. Options strategies should favor defined-risk credit spreads (sell $25 / buy $22.50) or buy protective puts if long equity. Cross-asset: a sharp rise in rates would widen insurer liability marks and could push realized vol above the 36% trailing base, turning skew into losses for short-put sellers.

Contrarian angle: Consensus treats the $25 put as low-risk (87% OTM) but the elevated put IV (54%) contradicts complacency — downside tail is priced but not fully capitalized by sellers. The high annualized YieldBoost for covered calls (25.96%) is an artifact of short-dated annualization and may be overdone relative to realized vol (36% TTM); mispricings exist for defined-risk sellers but not for naked shorts. Historical parallels to insurer repricings post-rate shocks warn that selling downside without floors can be costly if macro or claim events trigger rapid re-rating.

Key Decisions for Investors

• Establish a defined-risk income position in CRBG: sell Feb-20 $25 / buy $22.50 put verticals sized to 1–3% of portfolio notional, target net credit ≥ $0.02–$0.05; close or hedge if CRBG ≤ $24.00 or IV > 70% (protects against tail assignment).
• If willing to own the equity, buy CRBG up to 2–3% weight and sell Feb-20 $31 covered calls at $0.95; use a hard stop-loss at 10% below entry (~$27.30) and roll calls only if share price > $31 to capture 5.24% to assignment or keep 3.13% if expired worthless.
• If asymmetric downside is a concern, buy 3-month protective puts (e.g., $28 strike) sized 0.5–1% of portfolio or enter a put calendar to pay lower front-month premium; execute if implied put IV falls below 60% or if 10y Treasury moves +25bp within a week.
• Monitor three objective triggers over the next 2–8 weeks before scaling: (1) CRBG implied-put IV gap (put IV–call IV) >15ppt, (2) 10y UST moves >25–50bp, (3) any CRBG CDS widening >50bp — act to hedge or reduce exposure if two of three occur.